Kuban DA - Search Results

1

Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis.

Hung AY, Levy L, Kuban DA. Hung AY, et al. Among authors: kuban da. Cancer J. 2002 Nov-Dec;8(6):440-4. doi: 10.1097/00130404-200211000-00007. Cancer J. 2002. PMID: 12500852

2

The significance of post-irradiation prostate biopsy with long-term follow-up.

Kuban DA, el-Mahdi AM, Schellhammer P. Kuban DA, et al. Int J Radiat Oncol Biol Phys. 1992;24(3):409-14. doi: 10.1016/0360-3016(92)91053-p. Int J Radiat Oncol Biol Phys. 1992. PMID: 1399724

3

I-125 interstitial implantation for prostate cancer. What have we learned 10 years later?

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Cancer. 1989 Jun 15;63(12):2415-20. doi: 10.1002/1097-0142(19890615)63:12<2415::aid-cncr2820631207>3.0.co;2-u. Cancer. 1989. PMID: 2720587

4

Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Cancer. 1989 Jun 15;63(12):2421-5. doi: 10.1002/1097-0142(19890615)63:12<2421::aid-cncr2820631208>3.0.co;2-1. Cancer. 1989. PMID: 2720588

5

The effect of TURP on prognosis in prostatic carcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1653-9. doi: 10.1016/0360-3016(87)90161-1. Int J Radiat Oncol Biol Phys. 1987. PMID: 3667372

6

Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.

Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Kim JA, et al. Among authors: kuban da. Radiology. 1995 Feb;194(2):545-9. doi: 10.1148/radiology.194.2.7529936. Radiology. 1995. PMID: 7529936

7

Potential benefit of improved local tumor control in patients with prostate carcinoma.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Cancer. 1995 May 1;75(9):2373-82. doi: 10.1002/1097-0142(19950501)75:9<2373::aid-cncr2820750930>3.0.co;2-2. Cancer. 1995. PMID: 7536125

8

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):307-16. doi: 10.1016/0360-3016(95)00137-N. Int J Radiat Oncol Biol Phys. 1995. PMID: 7538499

9

Prognostic significance of post-irradiation prostate biopsies.

Kuban DA, el-Mahdi AM, Schellhammer PF. Kuban DA, et al. Oncology (Williston Park). 1993 Feb;7(2):29-38; discussion 40, 43-4, 47. Oncology (Williston Park). 1993. PMID: 7679918 Review.

10

High dose rate vaginal brachytherapy in early stage endometrial carcinoma: preliminary analysis.

Hong JJ, Yacoub SF, Blevins JC, Kuban DA, el-Mahdi AM. Hong JJ, et al. Among authors: kuban da. Am J Clin Oncol. 1997 Jun;20(3):254-8. doi: 10.1097/00000421-199706000-00009. Am J Clin Oncol. 1997. PMID: 9167748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters